XRF ScientificASX:XRF 100 3-Year ROIIC % is 36.71 as of Jun. 2025, which is 3% below its 10-year median of 37.94. GuruFocus rates ASX:XRF with a GF Score™ of 100/100 and a GF Value™ of A$1.65 (Fairly Valued). The stock has 1 warning sign investors should review. Among 526 Conglomerates companies, XRF Scientific ranks better than 88.02% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
XRF Scientific's 3-Year ROIIC % for the quarter that ended in Jun. 2025 was 36.71%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for XRF Scientific's 3-Year ROIIC % or its related term are showing as below:
ASX:XRF's 3-Year ROIIC % is ranked better than 88.02% of 526
companies
in the Conglomerates industry
Industry Median: 1.595
vs ASX:XRF: 36.71
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
XRF Scientific 3-Year ROIIC % Related Terms
XRF Scientific 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for XRF Scientific's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Conglomerates subindustry, XRF Scientific's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
XRF Scientific 3-Year ROIIC % vs Conglomerates Industry
For the Conglomerates industry and Industrials sector, XRF Scientific's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where XRF Scientific's 3-Year ROIIC % falls into.
XRF Scientific's 3-Year ROIIC % for the quarter that ended in Jun. 2025 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( 9.1106015 (Jun. 2025) - 5.2467652 (Jun. 2022) )
/
( 56.209 (Jun. 2025) - 45.685 (Jun. 2022) )
=
3.8638363
/
10.524
=
36.71%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
XRF Scientific (ASX:XRF) has a 3-Year ROIIC % of 36.71 as of Jun. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on XRF Scientific and its competitors. This is near median its historical median of 37.94. According to the industry distribution chart, XRF Scientific ranks #63 out of 526 companies in the Conglomerates industry, placing it in the top 12%.
Is XRF Scientific's 3-Year ROIIC % too high?
XRF Scientific's current 3-Year ROIIC % of 36.71 is near median its 10-year median of 37.94. The Conglomerates industry median 3-Year ROIIC % is 1.60. XRF Scientific's value of 36.71 is 2201.6% above this industry median. Based on the distribution chart, XRF Scientific ranks #63 out of 526 companies in the Conglomerates industry, which is in the top quartile — a strong position relative to peers. Overall, XRF Scientific has a GF Score™ of 100/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does XRF Scientific's 3-Year ROIIC % compare to HON and MMM?
According to the Conglomerates industry distribution chart, XRF Scientific ranks #63 out of 526 companies for 3-Year ROIIC %. This places XRF Scientific in the top 12% of its industry — outperforming the majority of peers. The industry median 3-Year ROIIC % is 1.60. XRF Scientific's value of 36.71 is 2201.6% above this benchmark. While the company's 10-year median is 37.94 vs. the industry median of 1.60, XRF Scientific has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Conglomerates company?
The median 3-Year ROIIC % among Conglomerates companies is 1.60, based on 526 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. XRF Scientific's current 3-Year ROIIC % of 36.71 is 2201.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on XRF Scientific and its competitors. For the Conglomerates industry, the median 3-Year ROIIC % is 1.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. XRF Scientific's current 3-Year ROIIC % is 36.71, which is near median its own 10-year median of 37.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is XRF Scientific stock overvalued right now?
Based on GuruFocus' analysis, XRF Scientific (ASX:XRF) is currently considered Fairly Valued. The stock's GF Value™ is A$1.65, compared to a current price of A$1.71 — trading 3.6% above its estimated fair value. The current 3-Year ROIIC % is 36.71, which is near median its 10-year median of 37.94 and 2201.6% above the Conglomerates industry median of 1.60. XRF Scientific's overall GF Score™ is 100/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For XRF Scientific (ASX:XRF), the current 3-Year ROIIC % is 36.71 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is XRF Scientific (ASX:XRF) Overvalued in 2026?
Based on GuruFocus' analysis, XRF Scientific stock appears to be overvalued.
The current stock price of A$1.71 is trading 3.6% above its estimated GF Value™ of A$1.65.
GuruFocus considers XRF Scientific to be Fairly Valued.
Key valuation signals for ASX:XRF:
3-Year ROIIC %: 36.71 (near median its 10-year median of 37.94)
GF Value™: A$1.65 vs. price of A$1.71 (3.6% above fair value)
Industry Position: 2201.6% above the Conglomerates median (#63 of 526)
No single metric tells the full story. See the ASX:XRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
XRF Scientific Ltd is engaged in the business of manufacturing and marketing precious metal products, specialized chemicals and instruments for the scientific, analytical and mining industries. It operates through the following segments: Capital Equipment, Precious Metals, and Consumables. The company generates maximum revenue from the Capital Equipment segment that Manufactures sample preparation products and analytical instruments. Geographically, it derives a majority of revenue from Australia and also has a presence in Canada and Europe. Some of its product includes Electric Fusion Machines; Fusion Flux; Crushing and Pulverising, platinum lab ware and others.
100GF Score
Get the complete analysis for ASX:XRF
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:XRF has been successfully added to your 
